Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2007 1
2008 2
2011 1
2012 3
2013 1
2014 2
2015 2
2016 4
2019 1
2021 2
2022 3
2024 3
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Hartmann's procedure versus sigmoidectomy with primary anastomosis for perforated diverticulitis with purulent or faecal peritonitis (LADIES): a multicentre, parallel-group, randomised, open-label, superiority trial.
Lambrichts DPV, Vennix S, Musters GD, Mulder IM, Swank HA, Hoofwijk AGM, Belgers EHJ, Stockmann HBAC, Eijsbouts QAJ, Gerhards MF, van Wagensveld BA, van Geloven AAW, Crolla RMPH, Nienhuijs SW, Govaert MJPM, di Saverio S, D'Hoore AJL, Consten ECJ, van Grevenstein WMU, Pierik REGJM, Kruyt PM, van der Hoeven JAB, Steup WH, Catena F, Konsten JLM, Vermeulen J, van Dieren S, Bemelman WA, Lange JF; LADIES trial collaborators. Lambrichts DPV, et al. Lancet Gastroenterol Hepatol. 2019 Aug;4(8):599-610. doi: 10.1016/S2468-1253(19)30174-8. Epub 2019 Jun 6. Lancet Gastroenterol Hepatol. 2019. PMID: 31178342 Clinical Trial.
Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial.
Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, Bechstein WO, Primrose JN, Walpole ET, Finch-Jones M, Jaeck D, Mirza D, Parks RW, Mauer M, Tanis E, Van Cutsem E, Scheithauer W, Gruenberger T; EORTC Gastro-Intestinal Tract Cancer Group; Cancer Research UK; Arbeitsgruppe Lebermetastasen und–tumoren in der Chirurgischen Arbeitsgemeinschaft Onkologie (ALM-CAO); Australasian Gastro-Intestinal Trials Group (AGITG); Fédération Francophone de Cancérologie Digestive (FFCD). Nordlinger B, et al. Among authors: tanis e. Lancet Oncol. 2013 Nov;14(12):1208-15. doi: 10.1016/S1470-2045(13)70447-9. Epub 2013 Oct 11. Lancet Oncol. 2013. PMID: 24120480 Clinical Trial.
A Comprehensive Study of N-Butyl-1H-Benzimidazole.
Kazachenko AS, Tanış E, Akman F, Medimagh M, Issaoui N, Al-Dossary O, Bousiakou LG, Kazachenko AS, Zimonin D, Skripnikov AM. Kazachenko AS, et al. Among authors: tanis e. Molecules. 2022 Nov 14;27(22):7864. doi: 10.3390/molecules27227864. Molecules. 2022. PMID: 36431965 Free PMC article.
Timing of Fracture Fixation in Ankle Fracture-Dislocations.
Penning D, Tausendfreund J, Naryapragi MA, Reisinger KW, Joosse P, Tanis E, Schepers T. Penning D, et al. Among authors: tanis e. Foot Ankle Spec. 2024 Oct 5:19386400241273105. doi: 10.1177/19386400241273105. Online ahead of print. Foot Ankle Spec. 2024. PMID: 39367857 Free article.
Shared decision-making for non-operative management versus operative management of hip fractures in selected frail older adults with a limited life expectancy: a protocol for a nationwide implementation study.
Zeelenberg ML, Oosterwijk PC, Willems HC, Gosens T, Den Hartog D, Joosse P, Loggers SAI, Nijdam TM, Pel-Littel RE, Polinder S, Schuijt HJ, Wijnen HH, Van der Velde D, Van Lieshout EMM, Verhofstad MHJ; NOM-Implementation study group. Zeelenberg ML, et al. BMJ Open. 2024 Apr 17;14(4):e083429. doi: 10.1136/bmjopen-2023-083429. BMJ Open. 2024. PMID: 38631829 Free PMC article.
U.S. Disability Services and Spending.
Hemp R, Braddock D, Tanis ESh, King M. Hemp R, et al. Among authors: tanis esh. NCSL Legisbrief. 2016 May;24(18):1-2. NCSL Legisbrief. 2016. PMID: 27825192 No abstract available.
CXCR4 and hif-1α as prognostic molecular markers for stage 3 colon cancer patients: post hoc analysis of the randomized, multicenter phase 3 PETACC-2 trial dataset.
Maderer A, Fiteni F, Tanis E, Mauer M, Schmitt T, Aust DE, Lutz MP, Roelofson F, Gog C, Weinmann A, Koehne CH, Moehler M, Thomaidis T. Maderer A, et al. Among authors: tanis e. Acta Oncol. 2021 Nov;60(11):1543-1547. doi: 10.1080/0284186X.2021.1959057. Epub 2021 Aug 6. Acta Oncol. 2021. PMID: 34355650 Clinical Trial. No abstract available.
26 results